# Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck

> **NCT00096174** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 69 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** cetuximab C225
- **DRUG:** cisplatin
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00096174
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04-08
- **Primary completion:** 2009-07
- **Final completion:** 2016-07
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2023-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00096174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00096174, "Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00096174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*